# Immunogenicity of COVID-19 Vaccination in PLWH

> **NCT04894448** · — · UNKNOWN · sponsor: **CIHR Canadian HIV Trials Network** · enrollment: 500 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** COVID-19 Vaccine

## Key facts

- **NCT ID:** NCT04894448
- **Lead sponsor:** CIHR Canadian HIV Trials Network
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-10
- **Primary completion:** 2022-03-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04894448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04894448, "Immunogenicity of COVID-19 Vaccination in PLWH". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04894448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*